NorthCrest Asset Manangement’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$428K Hold
35,100
– – 0.01% 701
2026
Q2
$488K Sell
35,100
-375
-1% -$5.06K 0.01% 568
2026
Q1
$473K Sell
35,475
-17,250
-33% -$240K 0.01% 499
2025
Q4
$729K Sell
52,725
-1,050
-2% -$14.7K 0.02% 440
2025
Q3
$754K Sell
53,775
-750
-1% -$10.8K 0.02% 390
2025
Q2
$822K Sell
54,525
-500
-0.9% -$7.14K 0.02% 337
2025
Q1
$726K Hold
55,025
– – 0.02% 357
2024
Q4
$869K Sell
55,025
-450
-0.8% -$6.76K 0.03% 316
2024
Q3
$881K Sell
55,475
-500
-0.9% -$8.05K 0.03% 309
2024
Q2
$853K Hold
55,975
– – 0.03% 295
2024
Q1
$821K Buy
55,975
+1,550
+3% +$22.6K 0.03% 295
2023
Q4
$757K Sell
54,425
-350
-0.6% -$4.68K 0.03% 302
2023
Q3
$733K Sell
54,775
-1,700
-3% -$23K 0.03% 290
2023
Q2
$713K Sell
56,475
-975
-2% -$11.4K 0.03% 303
2023
Q1
$654K Hold
57,450
– – 0.03% 314
2022
Q4
$595K Hold
57,450
– – 0.03% 249
2022
Q3
$601K Hold
57,450
– – 0.03% 274
2022
Q2
$636K Hold
57,450
– – 0.03% 275
2022
Q1
$640K Sell
57,450
-150
-0.3% -$1.7K 0.03% 260
2021
Q4
$754K Buy
+57,600
New +$726K 0.04% 260

Other funds holding RDY

NorthCrest Asset Manangement's RDY Position: Q3 2026 in Review

NorthCrest Asset Manangement held its Dr. Reddy's Laboratories (RDY) position steady in Q3 2026 at 35,100 shares worth $428K. The position accounts for 0.01% of the portfolio, ranked #701.

NorthCrest Asset Manangement first reported a position in RDY in Q4 2021 and has held it in 20 quarters since. The position peaked at $881K in Q3 2024. 13 funds tracked by Wall St. Rank hold RDY as of Q3 2026.

  • NorthCrest Asset Manangement held 35,100 shares of Dr. Reddy's Laboratories worth $428K as of Q3 2026.
  • NorthCrest Asset Manangement left its Dr. Reddy's Laboratories share count unchanged in Q3 2026.
  • Dr. Reddy's Laboratories made up 0.01% of NorthCrest Asset Manangement's portfolio in Q3 2026, its #701 holding.
  • NorthCrest Asset Manangement first reported a position in Dr. Reddy's Laboratories in Q4 2021 and has held it in 20 quarters since.
  • NorthCrest Asset Manangement's Dr. Reddy's Laboratories position peaked at $881K in Q3 2024.
  • 13 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q3 2026, filed 13 Oct 2026.